4
Views
17
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATIONS

Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria?

Page 165 | Received 07 Oct 1983, Published online: 15 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

L. Donno. (1989) Drug Combinations in the Treatment of Malaria . Journal of Chemotherapy 1:1, pages 52-58.
Read now

Articles from other publishers (16)

Carnevale P, Carnevale N, Toto JC, Foumane V, Martineaud F & Manguin S. (2022) Long-term evolution of Plasmodium falciparum gametocytes index during a village scale malaria vector control program comparing durable lining, long-lasting treated net and indoor residual spraying in Angola. MOJ Public Health 11:1, pages 17-26.
Crossref
Bharathi Avula, Babu L. Tekwani, Narayan D. Chaurasiya, Pius Fasinu, N. P. Dhammika Nanayakkara, H. M. T. Bhandara Herath, Yan-Hong Wang, Ji-Yeong Bae, Shabana I. Khan, Mahmoud A. Elsohly, James D. McChesney, Peter A. Zimmerman, Ikhlas A. Khan & Larry A. Walker. (2018) Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Malaria Journal 17:1.
Crossref
Karin Leder & Peter F. Weller. 2015. Manual of Clinical Microbiology . Manual of Clinical Microbiology 2527 2549 .
Karin Leder & Peter F. Weller. 2011. Manual of Clinical Microbiology. Manual of Clinical Microbiology 2275 2295 .
Rie Takeuchi, Saranath Lawpoolsri, Mallika Imwong, Jun Kobayashi, Jaranit Kaewkungwal, Sasithon Pukrittayakamee, Supalap Puangsa-art, Nipon Thanyavanich, Wanchai Maneeboonyang, Nicholas PJ Day & Pratap Singhasivanon. (2010) Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malaria Journal 9:1.
Crossref
M. Oliver, F. Simon, F. de Monbrison, A.H. Beavogui, B. Pradines, C. Ragot, J.L. Moalic, C. Rapp & S. Picot. (2008) Le nouvel âge de la primaquine contre le paludisme. Médecine et Maladies Infectieuses 38:4, pages 169-179.
Crossref
H. AsschemanL.G. Visser. 2006. Vademecum permanente nascholing huisartsen. Vademecum permanente nascholing huisartsen 1819 1820 .
W Robert J Taylor & Nicholas J White. (2004) Antimalarial Drug Toxicity. Drug Safety 27:1, pages 25-61.
Crossref
J. Kevin Baird, D. J. Fryauff & S. L. Hoffman. (2003) Primaquine for Prevention of Malaria in Travelers. Clinical Infectious Diseases 37:12, pages 1659-1667.
Crossref
J.Kevin Baird & Karl H. Rieckmann. (2003) Can primaquine therapy for vivax malaria be improved?. Trends in Parasitology 19:3, pages 115-120.
Crossref
S. Looareesuwan, P. Wilairatana, R. Glanarongran, K.A. Indravijit, L. Supeeranontha, S. Chinnapha, T.R. Scott & J.D. Chulay. (1999) Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93:6, pages 637-640.
Crossref
I. Ittarat, W. Asawamahasakda, M. S. Bartlett, J. W. Smith & S. R. Meshnick. (1995) Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrobial Agents and Chemotherapy 39:2, pages 325-328.
Crossref
F B Cogswell. (1992) The hypnozoite and relapse in primate malaria. Clinical Microbiology Reviews 5:1, pages 26-35.
Crossref
D.C. Warhurst. (1987) Primaquine: Pharmacokinetics, metabolism, toxicity and activity. Parasitology Today 3:11, pages 353-355.
Crossref
H.V. Scott, K.H. Rieckmann & W.J. O'Sullivan. (1987) Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 81:5, pages 715-721.
Crossref
R. E. Howells. (2009) The modes of action of some anti-protozoal drugs. Parasitology 90:4, pages 687-703.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.